Awassi sheep reproduction and milk production: review

Awassi is the local breed of sheep in Jordan and is the most important breed in the semi-arid regions of the near east countries. Awassi ram and ewe lambs reach puberty at around 8 and 9 months of age, respectively. The breeding season of Awassi ewes starts as early as April and lasts through September. After puberty, Awassi rams are sexually active throughout the year. The normal estrous cycle in Awassi ewes is 15-20 days (average 17 days). Estrus ranges from 16-59 h (average 29 h) during the breeding season. The reproductive performance of unimproved Awassi sheep has been low while improved Awassi has the highest fertility and milk production and are the heaviest among all Awassi populations. The gestation length varies from 149 to 155 days (average 152 days). Hormones that are commonly used for induction and synchronization of estrus in Awassi ewes include progestins, gonadotropins and PGF2α. An Awassi ewe produces 40-60 and 70-80 kg of milk per 150-day lactation period under traditional and improved production systems, respectively, in addition to the suckled milk left for lambs until weaning. The improved Awassi has the highest milk production among all Awassi populations and may reach 506 L over 214-day lactation period. The objective of this review is to summarize the reproductive pattern and milk production of Awassi sheep in the Middle East region.

Recombinant adeno-associated virus-mediated in utero gene transfer gives therapeutic transgene expression in the sheep

Somatic in utero gene therapy aims to treat congenital diseases where pathology develops in perinatal life, thereby preventing permanent damage. The aim of this study was to determine whether delivery of self-complementary (sc) adeno-associated virus (AAV) vector in utero would provide therapeutic long-term transgene expression in a large animal model. We performed ultrasound-guided intraperitoneal injection of scAAV2/8-LP1-human Factor IX (hFIX)co (1 × 10(12) vector genomes/kg) in early (n = 4) or late (n = 2) gestation fetal sheep. The highest mean hFIX levels were detected 3 weeks after injection in late gestation (2,055 and 1,687.5 ng/ml, n = 2) and 3 days after injection in early gestation (435 ng/ml, n = 1). Plasma hFIX levels then dropped as fetal liver and lamb weights increased, although low levels were detected 6 months after late gestation injection (75 and 52.5 ng/ml, n = 2). The highest vector levels were detected in the fetal liver and other peritoneal organs; no vector was present in fetal gonads. hFIX mRNA was detectable only in hepatic tissues after early and late gestation injection. Liver function tests and bile acid levels were normal up to a year postnatal; there was no evidence of liver pathology. No functional antibodies to hFIX protein or AAV vector were detectable, although lambs mounted an antibody response after injection of hFIX protein and Freund's adjuvant. In conclusion, hFIX expression is detectable up to 6 months after delivery of scAAV vector to the fetal sheep using a clinically applicable method. This is the first study to show therapeutic long-term hFIX transgene expression after in utero gene transfer in a large animal model.

Growth and metabolism of the ovine placenta during mid-gestation

The timing and metabolic basis for the rapid increase then cessation of placental growth in sheep and the accompanying changes in tissue cellularity were defined in the present study. Placental growth proceeded rapidly from day 40 of gestation to an apex at day 75-80 with no change is tissue dry matter content observed thereafter to day 100. These macroscopic growth patterns are similar to those observed previously, but present results define an earlier apex in placental mass. Absolute growth rate of the placenta reached a maximum near day 55, as derived from the Gompertz equation, concomitant with a period of maximum hyperplastic growth between days 50 and 60. A rapid increase in DNA synthesis and tissue mass per nuclei number from day 40-50 was followed by proliferative growth to day 70. Net cellular proliferation apparently ceased by day 80 as indicated by the apex in DNA content and the beginning of a static, low rate of DNA synthesis that continued to day 100. Patterns of change in the fractional rates of protein synthesis (Ks) and accretion (Kg) were similar suggesting that changes in Ks explain much of the change in Kg. This study, through its identification of key phases in the cellular growth of the ovine placenta, has laid the foundation for future research on mechanisms of placental growth regulation.

Effect of nutrition during pregnancy on fetal growth and survival in FecB Booroola × South Australian Merino ewes

The effect of nutritional manipulation during mid and late pregnancy on fetal growth and survival in high fecundity (Fec(B) Fec(+)) Merino ewes was examined. A total of 4 treatment groups was utilized in each of 3 years (1987, 1988 and 1989); and 2 groups were given low nutrition during mid pregnancy while 2 groups received high nutrition during this period. One group from each of these treatments subsequently received a high protein diet 1 to 2 weeks prior to term. Differential feeding during mid pregnancy resulted in the high and low treatment groups varying by 7.5 and 5.0 kg liveweight at Days 100 and 135 of pregnancy, respectively. Fetal survival was not improved by variation in nutritional intake during mid pregnancy (P>0.05) and neither were placental and fetal growth (P>0.05), as indicated by observations on cotyledon diameter and fetal head width, respectively. However, fetal survival during late pregnancy was reduced by a high level of nutrition during both mid and late pregnancy (P<0.05).

Fetal and maternal Doppler flow velocity waveforms in normal sheep pregnancy

Abnormalities in placental vascular resistance have been shown to have an important association with intrauterine growth retardation in both human and sheep pregnancies. In this study we have assessed impedance to blood flow through the ovine placental circulation by Doppler flow velocity waveform analysis. As gestation advanced from 66 to 136 days, a significant decrease in impedance to flow was observed in both umbilical and maternal placental arteries. The greatest decrease in impedance was observed between 66 and 109 days' gestation in umbilical arteries and between 66 and 80 days' gestation in maternal placental arteries. In these normal pregnancies, no significant correlations could be found between Doppler flow velocity waveform analyses and fetal or placental growth. We conclude that Doppler flow velocity waveform analysis is a valuable and non-invasive method to assess impedance to blood flow through the placental circulation in pregnant sheep.